RPHM   $18.2  5.20% Market Closed

Reneo Pharmaceuticals Inc
Total Cash 76.67M
totalCashPerShare 2.294
EBITDA -61.06M
Total Debt 823.00K
quickRatio 56.88
currentRatio 57.856
Total Revenue
debtToEquity 1.071
Revenue/Share
ROA -0.33721
ROE -0.54
grossProfits
freeCashflow -43.42M
operatingCashflow -66.34M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -24.70M
forwardPE
floatShares 8.13M
sharesOutstanding 33.43M
sharesShort 3.40M
sharesShortPriorMonth 3.26M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.88%
Short Ratio help_outline 27.39%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 2.3
Price To Book help_outline 0.70
earningsQuarterlyGrowth
netIncomeToCommon -56.54M
trailingEps -1.68%
forwardEps -0.38%
enterpriseToEbitda 0.41
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 3Q 2024
institutionsCount 89
lastUpdated Sept. 27, 2024, 2:54 a.m.